This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
September 18, 2024
Vicore Publishes Prospectus Relating to the Rights Issue
September 17, 2024
Vicore Announces Additional Subscription Undertaking from HealthCap
September 12, 2024
Oncopeptides signs license agreement with SCBIO for Pepaxti in South Korea
September 10, 2024
Carisma and Moderna Expand Collaboration to Develop Two In Vivo CAR-M Therapies for Autoimmune Diseases
September 10, 2024
Vicore Initiates the Global, Randomized Phase 2b ASPIRE Trial Evaluating the Disease-Modifying Potential of Buloxibutid in Idiopathic Pulmonary Fibrosis
September 10, 2024
Vicore Pharma announces a rights issue of approximately SEK 782 million
September 09, 2024
Pulmonx Announces Presentation of Clinical Data from the AeriSeal® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024
September 05, 2024
European Commission Grants Orphan Drug Designation for Vivet Therapeutics Gene Therapy Product for the Treatment of Cerebrotendinous Xanthomatosis (CTX)
September 05, 2024
BONESUPPORT – Top line SOLARIO data presented at EBJIS
August 29, 2024
Vicore Announces Presentations at the European Respiratory Society Congress 2024